Latest Breaking News On - Longboard pharmaceuticals - Page 5 : comparemela.com

HC Wainwright reaffirmed their buy rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $60.00 price objective on the stock. LBPH has been the topic of a number of other reports. Guggenheim increased their price objective on […]

Arena pharmaceuticals incNews ratings for longboard pharmaceuticals dailyVanguard group incJpmorgan chase coLongboard pharmaceuticals company profileLongboard pharmaceuticals incBlackrock incPolar capital holdings plcCantor fitzgeraldSecurities exchange commissionLongboard pharmaceuticalsAnalyst recommendations for longboard pharmaceuticalsLongboard pharmaceuticals stock downFree reportPharmaceuticals stock downGet free report